Literature DB >> 23232066

Diurnal rhythm rather than dietary iron mediates daily hepcidin variations.

Charlotte C M Schaap1, Jan C M Hendriks, Guus A M Kortman, Siem M Klaver, Joyce J C Kroot, Coby M M Laarakkers, Erwin T Wiegerinck, Harold Tjalsma, Mirian C H Janssen, Dorine W Swinkels.   

Abstract

BACKGROUND: The iron-regulating hormone hepcidin is a promising biomarker in the diagnosis of iron disorders. Concentrations of hepcidin have been shown to increase during the day in individuals who are following a regular diet. It is currently unknown whether these increases are determined by an innate rhythm or by other factors. We aimed to assess the effect of dietary iron on hepcidin concentrations during the day.
METHODS: Within a 7-day interval, 32 volunteers received an iron-deficient diet on 1 day and the same diet supplemented with 65 mg ferrous fumarate at 0815 and 1145 on another day. Blood was drawn to assess ferritin, hepcidin-25, and transferrin saturation (TS) throughout both days at 4 time points between 0800 (fasted) and 1600. A linear mixed model for repeated data was used to analyze the effect of iron intake on TS and hepcidin concentrations.
RESULTS: Baseline values of hepcidin at 0800 correlated significantly with ferritin (r = 0.61). During the day of an iron-deficient diet the mean TS was similar both in men and in women, whereas hepcidin increased. During the day with iron supplementation the mean TS was significantly higher both in men and in women, and the mean hepcidin was moderately but significantly higher in women (1.0 nmol/L, 95% CI, 0.2-1.8) but not in men (0.0 nmol/L, 95% CI, -0.8 to 0.8).
CONCLUSIONS: Our data demonstrate that ferritin sets the basal hepcidin concentrations and suggest that innate diurnal rhythm rather than dietary iron mediates the daily hepcidin variations. These findings will be useful for optimizing sampling protocols and will facilitate the interpretation of hepcidin as an iron biomarker.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23232066     DOI: 10.1373/clinchem.2012.194977

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  24 in total

1.  Effect of iron supplementation during lactation on maternal iron status and oxidative stress: A randomized controlled trial.

Authors:  Josh M Jorgensen; Zhenyu Yang; Bo Lönnerdal; Caroline J Chantry; Kathryn G Dewey
Journal:  Matern Child Nutr       Date:  2016-11-29       Impact factor: 3.092

2.  Does Improvement of Low Serum Ferritin Improve Symptoms of Restless Legs Syndrome in a Cohort of Pediatric Patients?

Authors:  Gerald M Rosen; Sue Morrissette; Amy Larson; Pam Stading; Timothy L Barnes
Journal:  J Clin Sleep Med       Date:  2019-08-15       Impact factor: 4.062

3.  Pilot study of the effect of cholecalciferol supplementation on hepcidin in children with chronic kidney disease: Results of the D-fense Trial.

Authors:  Meredith A Atkinson; Stephen P Juraschek; Michael S Bertenthal; Barbara Detrick; Susan L Furth; Edgar R Miller
Journal:  Pediatr Nephrol       Date:  2016-12-24       Impact factor: 3.714

Review 4.  Iron deficiency anaemia in pregnancy: A contemporary review.

Authors:  Charlotte S Benson; Akshay Shah; Matthew C Frise; Charlotte J Frise
Journal:  Obstet Med       Date:  2020-07-07

Review 5.  Dietary Iron and the Elite Dancer.

Authors:  Caitlin Attwell; Cory Dugan; Alannah K A McKay; Joanna Nicholas; Luke Hopper; Peter Peeling
Journal:  Nutrients       Date:  2022-05-05       Impact factor: 6.706

Review 6.  Iron considerations for the athlete: a narrative review.

Authors:  Marc Sim; Laura A Garvican-Lewis; Gregory R Cox; Andrew Govus; Alannah K A McKay; Trent Stellingwerff; Peter Peeling
Journal:  Eur J Appl Physiol       Date:  2019-05-04       Impact factor: 3.078

7.  Clinical Immunoassay for Human Hepcidin Predicts Iron Deficiency in First-Time Blood Donors.

Authors:  Patrick Gutschow; Huiling Han; Gordana Olbina; Keith Westerman; Elizabeta Nemeth; Tomas Ganz; Karen Copeland; Mark Westerman; Vaughn Ostland
Journal:  J Appl Lab Med       Date:  2020-09-01

8.  Prepregnancy Obesity Is Not Associated with Iron Utilization during the Third Trimester.

Authors:  Mary Dawn Koenig; Elizabeth Klikuszowian; Kimberly O O'Brien; Heather Pauls; Alana Steffen; Victoria DeMartelly; Rungnapa Ruchob; Lauren Welke; Nefertiti Hemphill; Bazil LaBomascus; Lacey Pezley; Andrew McLeod; Bruni Hirsch; Carol Estwing Ferrans; Lisa Tussing-Humphreys
Journal:  J Nutr       Date:  2020-06-01       Impact factor: 4.798

9.  Serum hepcidin in infants born after 32 to 37 wk of gestational age.

Authors:  Lieke Uijterschout; Magnus Domellöf; Staffan K Berglund; Micky Abbink; Paul Vos; Lyanne Rövekamp; Bart Boersma; Carina Lagerqvist; Cisca Hudig; Johannes B van Goudoever; Frank Brus
Journal:  Pediatr Res       Date:  2015-12-16       Impact factor: 3.756

10.  Single versus Split Dose of Iron Optimizes Hemoglobin Mass Gains at 2106 m Altitude.

Authors:  Rebecca Hall; Peter Peeling; Elizabeta Nemeth; Dan Bergland; Walter T P McCluskey; Trent Stellingwerff
Journal:  Med Sci Sports Exerc       Date:  2019-04       Impact factor: 5.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.